Hermès, Layer 2: Dislocation Assessment

Purpose and scope. This document exists because a trigger fired: the shares have fallen far enough to warrant the work. It does two things, strictly in order. First, it retests the moat cold, against the invalidation conditions fixed in the Layer 1 foundation document, to determine whether this decline is sentiment and forced selling or genuine structural impairment. Only if the moat passes does it proceed to the second task: assessing whether the current price is an attractive entry, and specifying the plan. The ordering is deliberate. The moat verdict is reached before any price or valuation is examined, so that an attractive price cannot manufacture a favourable reading of the business.

The spine of the case, stated once so the rest can be read against it. The recovery thesis does not rest on the market being irrational, on any hidden fact, or on out predicting the sell side. It rests on a single mechanism: if the moat is intact and stays intact, earnings keep compounding, and a compounding franchise recovers its price even if the multiple only holds, and recovers it powerfully if the multiple also reverts. Everything below serves that mechanism. The moat retest establishes that the franchise is intact now. The valuation section establishes that the price paid does not require the multiple to expand for the thesis to work. The plan treats the durability of the moat, the part of the claim that lives in the future and cannot be assumed, as a monitored variable with pre committed triggers rather than an article of faith.

Assessment date: 4 July 2026, resting on the Q1 2026 revenue release and on evidence gathered through early July. Trigger: drawdown through the Layer 1 alert threshold. Data sources: Hermès Q1 2026 revenue report, FY2025 key figures, market price and multiple history, an independent year end P/E series (2001 to 2024), Bernstein’s Secondhand Pricing Tracker (a volume weighted auction premium, accessed through press summaries rather than the primary note) and Rebag retention data, apex format spot resale floors (Vestiaire Collective, Ginza Xiaoma), Bain Altagamma spring 2026 and Bain China reports, recent sell side notes (Jefferies, Bernstein SocGen, Kepler Cheuvreux, Barclays, J.P. Morgan), and Global Blue tourism data. Each is tagged by evidence tier as in Layer 1, and systematic series are weighted above spot observations wherever both exist.

Recommendation: deploy 2/3 of target weight now; 1/3 reserved for tail Price / peak: €1,627 vs €2,957 (Feb 2025) — drawdown ~45% Trailing P/E: ~38x FY2025 EPS €43.1 (peak: ~68x FY2024 EPS €43.6) Market cap / EV: ~€171bn / ~€159bn (net cash €12.2bn) Moat verdict (retested): Intact: five gauges clean, one amber (resale premium) Base-case 5-yr IRR: ~11% Reserve trigger: ~27x trailing ≈ €1,165 (-29%), conditional on fresh moat verification Key checkpoint: 29 July H1 print: mechanical de-risk triggers on deployed tranche

Decision in one paragraph. The shares have fallen ~45% on roughly flat earnings — the entire decline is multiple compression, from a ~68x bubble peak to ~38x, the floor of the post-2018 trough regime. The moat retest, run against the Layer 1 invalidation register before any price was examined, passes on five of six gauges. At €1,627 the market prices roughly 12% long-run earnings compounding — continuation of the model, not acceleration — and even the reserve-tranche tail price embeds ~7%. The recovery mechanism requires only that the moat holds and earnings compound; multiple reversion is upside, not a requirement. Deploy 2/3 now; hold 1/3 for a regime-break tail that would itself demand fresh moat verification before deployment.

SECTION ONE, THE TRIGGER

The move. The shares last traded around EUR 1,627 against a February 2025 high of roughly EUR 2,957 (tier one, price data): a drawdown of approximately 44 to 45%, through the Layer 1 alert threshold of 40% and into the zone where the deep work begins. The decline was a grind, not an event: a first leg through mid 2025, a partial recovery, then a second, steeper leg into 2026 culminating in a fall of as much as 14% intraday on the Q1 print of 15 April.

The relative dislocation. This is not an idiosyncratic Hermès collapse. Kering and LVMH fell in sympathy, and the press frames the move as the market questioning whether luxury as a whole has peaked (tier two). Subject to the retest below, a large part of this is sector wide de rating rather than company specific impairment, the profile Layer 1 flagged as the most common source of a Hermès dislocation. One qualification is carried honestly from the outset: the Q1 print itself was a genuine miss (5.6% organic against roughly 7.1% consensus, down from 9.8% the prior quarter), so part of the fall is a repricing of the never disappoints premium, not pure sentiment. Section three weighs this.

The multiple compression. At roughly EUR 1,627 against 2025 earnings of roughly EUR 43 per share, the trailing multiple is approximately 38 times (tier one on both inputs). The peak was far higher than a casual read suggests: the 14 February 2025 all time high of roughly EUR 2,957, divided by trailing FY2024 earnings of roughly EUR 43.6 per share, was approximately 68 times, essentially the same nosebleed level as the 2021 spike. So the drawdown ran from about 68 times to about 38 times, a near halving of the multiple. A point that must be stated honestly rather than softened: across this specific window earnings were roughly flat (FY2024 EUR 43.6, FY2025 EUR 43.1), so the roughly 45% price fall was almost entirely multiple compression, not a case of the multiple falling while earnings grew underneath. That cuts against one easy comfort and reinforces a more important reading: an unchanged business de rating from a genuine bubble peak back toward its post 2018 floor is valuation normalisation, not fundamental impairment. Whether roughly 38 trailing is that modern floor or a mid range level is the central valuation question of Section four.

The trigger tells us only that the work is warranted. It is not evidence about the moat, and nothing in this section is a view. The verdict comes from Section two.

SECTION TWO, THE MOAT RETEST, REACHED BEFORE ANY PRICE JUDGMENT Layer 1 fixed six invalidation conditions with quantified thresholds. This section walks each against the full current evidence, including the systematic series gathered since the quarter closed. The governing question: is the franchise impairing, or is the market selling it for reasons unrelated to the moat?

The lead indicator, core leather growth Layer 1 named constant currency growth of Leather Goods and Saddlery the lead indicator, with a healthy band of 8 to 12% and a concerning threshold below 6% sustained. Observation: Q1 2026 delivered +9% at constant exchange rates (EUR 1,849m against EUR 1,813m, tier one), attributed to strong collection desirability and increased production capacity, with specific new formats selling through well. Verdict: squarely within the healthy band. The single metric that would most directly reveal a broken franchise shows the core engine running normally. This is the most important fact in the assessment, and it is the direct evidence that the earnings compounding on which the whole recovery mechanism depends is still occurring.

Pricing power and production discipline The invalidating signature would be lost pricing power (increases producing volume declines) or abandoned discipline (capacity accelerating beyond the roughly 6 to 7% cadence to chase a number). Observation: the growth is being delivered by supply expanding into unmet demand, not by price cuts; the twenty fifth leather workshop opened at Loupes in April 2026, with further workshops pre committed at Charleville Mézières (2027), Colombelles (2028) and Les Andelys (2030), each on the multi year lead time Layer 1 described (tier one). Verdict: discipline intact and pricing power evident, a strong pass. One consequence is carried forward as a cost rather than only a virtue: this deliberate supply expansion mechanically compresses the resale premium (next test) and adds fixed cost that pressures margin when growth slows (Section four). The same discipline that protects the moat has effects elsewhere in the thesis that an honest reading must track.

The regional picture, and the source of decline Observation (tier one): group revenue EUR 4.07bn, up 6% at constant currency, down 1% as reported on a EUR 290m currency drag. Americas +17%, Japan +10%, Europe excluding France +10%. The weakness is concentrated: Asia excluding Japan +2% (Greater China in slight growth, Korea solid, the rest subdued), and the Other area, primarily the Middle East, down 6%, attributed to the Gulf geopolitical disruption from March; France down 3% on tourist flows.

Interpretation: Layer 1 pre identified a China regime effect and a broad sentiment or tourism shock as the two most probable moat unrelated triggers, and that is what the data shows. Two qualifications are weighed rather than waved away. First, even stripping the roughly 150 basis point Middle East effect, underlying growth of roughly 7% sat below the double digit cadence, and analysts noted residual softness not fully explained by the exogenous factors. Second, attributing the miss substantially to tourism sits uneasily with a decade of company messaging that Hermès sells overwhelmingly to locals; either the tourism exposure was quietly higher than advertised, or part of the softness is local demand wearing a tourism costume. Against this: mainland China recovered visibly from Q3 2025; Hermès grew FY2025 China revenue about 7% while the mainland market contracted 3 to 5%, which is share gain in a shrinking market; and the structural damage in Chinese luxury is barbell shaped, concentrated in the aspirational tier Hermès does not primarily serve. Verdict: predominantly cyclical and exogenous, on the moderate branch, but not entirely explained, which is why the 29 July checkpoint in Section five carries hard triggers rather than judgment calls.

The apex resale premium, amber

Layer 1 named the apex resale premium the cleanest real time gauge of the demand supply gap: healthy above 1.5 times retail, impairment below 1.2 times sustained. Two instruments exist and they measure different things, a distinction the reading must respect rather than blur. The first is boutique and reseller spot floors on the hottest configurations, which remain strong (Birkin 25 in black or gold around EUR 18,000 to 20,000, Mini Kelly around EUR 20,000, against roughly EUR 11,000 to 12,000 retail); these flatter the reading because they sample only the scarcest pieces. The second is Bernstein's Secondhand Pricing Tracker, which is a volume weighted auction premium, the auction sale price against retail, across the Birkin and Kelly range. The two are not rival estimates of one number; they sample different segments, and the auction series is the noisier and more sentiment sensitive of the two. This assessment reads the auction series for the trend and the dispersion, not the spot floors for comfort.

Observation (tier two, auction series, sourced through press summaries of the Bernstein tracker rather than the primary note): the blended average Birkin and Kelly auction premium fell from about 2.2 times retail in 2022 to about 1.4 times as of November 2025; Rebag's value retention of about 138% is a separate and differently constructed figure pointing the same broad direction. Read alone, that blended average looks like a clean multi year erosion toward the concern zone. But the average conceals a barbell that is the more informative signal, and it is visible inside the same data. The compression is concentrated in the large, common, high volume formats: the Birkin Togo 30 now prints around 1.0 times, no premium at all, down from about 1.7 times in 2022 (and, tellingly, about 1.9 times in 2018, so the series is lumpy rather than a straight line). The small and scarce formats show the opposite: the Mini Kelly and the 25 centimetre Birkin still command large premiums, with individual small format sales reported well above retail. The blended 1.4 times is therefore an aspirational tier deflating toward no premium averaged against a scarce tier that has barely moved, which is the same barbell the China section relies on, surfacing in the resale data itself. Two mitigants are now sourced rather than assumed. The 2022 peak was a pandemic auction mania, so part of the fall is normalisation; and the press sources explicitly attribute part of the pressure to rising secondhand supply and the four new factories, that is, to Hermès making more bags, which compresses the premium even with demand fully intact.

Required task before 29 July, decompose the compression. The decomposition is now partly pre answered by the barbell and the sourced supply attribution, which narrows rather than removes the work. Cumulative production capacity growth since 2022 is roughly 25 to 30% on the stated cadence, and the press sources name rising supply directly, so a meaningful share of the blended fall is mechanical. The task before the print is to separate, format by format, the supply and mania normalisation component from any residual demand cooling, using the scarce tier (barely moved) as the demand intact control and the common tier (Togo 30 to 1.0 times) as the stressed sample. Decision rule, fixed now: if the residual demand driven component plausibly explains more than half of the common format compression below the 2019 pre mania level of about 1.6 to 1.7 times, this gauge is downgraded to red and counts as one invalidation condition trending; if less than half, amber stands. One residual is kept honestly cautionary rather than explained away: a large, classic, high volume format sitting at no premium is the aspirational middle signalling something, and it is consistent with the migration risk Layer 1 named. Verdict as of this writing: amber, and specifically amber for the aspirational tier while the scarce tier the franchise most depends on remains intact; above retail and sector leading in aggregate, softened at the common end, with the residual demand component to be sized before the print.

Governance and family control

No change. Axel Dumas remains Executive Chairman, the long term strategy explicitly reaffirmed, share count and control structure unchanged; the EUR 60m buyback is immaterial to control (tier one). Verdict: intact.

Migration and cultural revaluation, the one thesis destroying risk

Layer 1 named the migration of apex signalling away from the leather object as the single non cyclical, potentially decisive risk. The near term data points the other way (+9% core leather on strong desirability). But the systematic evidence says the risk is advancing at the margin, not receding: Bain’s global luxury customer pool down from roughly 400m (2022) to 340m (2025), with further loss likely; leather goods the weakest major segment in mainland China in 2025 (down an estimated 8 to 11%); the guochao movement elevating local brands from challengers to market shapers; spending shifting toward experiences at roughly 1.5 times the pace of goods; and the resale premium downtrend above, consistent with this risk’s early signature even where supply explains part of it. Verdict: not materialising near term, but rated a live multi year watch item; the resale decomposition task doubles as this risk’s monitor.

Moat retest conclusion

• Core leather pricing power lost: no (+9% constant currency on strong desirability).

• Apex resale premium structurally eroded below 1.2 times: no, but amber. The blended auction premium is about 1.4 times and trending down, but the fall is a barbell: common formats at roughly 1.0 times, scarce formats still at large premiums, with part of the compression sourced to Hermès own supply expansion. Amber for the aspirational tier, intact for the scarce tier the franchise depends on; decomposition to be sized before the print.

• Production discipline abandoned: no (twenty fifth workshop open, pipeline committed to 2030).

• Allocation culture dismantled: no evidence; sell through strong.

• Younger cohorts migrating to other status media: no near term evidence, but the multi year indicators have worsened at the margin.

• Family control weakened: no.

Verdict: the moat is intact, five conditions clean and one amber. The decline is still substantially explained by currency, a Middle East shock, a decelerating but still positive China and sector de rating, the Layer 1 signature of a candidate opportunity, but the invincibility premium has cracked on a real miss, one gauge is amber, and a residual portion of the softness is unexplained. Those qualifications are carried into the sizing, not shed. On this verdict the assessment proceeds to price.

SECTION THREE, THE ANATOMY OF THE DECLINE With the franchise substantially intact, the second question is why the shares fell roughly 44%, because understanding the seller tells us whether the price is likely to be wrong. Four forces, none of them the moat, plus one that partially is:

• Currency. A EUR 290m translation drag turned +6% constant currency into a down 1% headline, an optics problem feeding a nervous tape (tier one).

• Sector de rating. The luxury complex fell together; Hermès is sold indiscriminately through sector baskets in such episodes, as Layer 1 warned (tier two).

• China proxy selling. A meaningful holder cohort trades Hermès as a liquid China proxy; the soft Asia excluding Japan print gave them the reason.

• Multiple normalisation from an extreme. The peak was roughly 68 times trailing (EUR 2,957 against FY2024 EPS of about EUR 43.6), a bubble level matching the 2021 spike and requiring near perfection. Because earnings were roughly flat across the window, essentially the entire fall is this extreme unwinding, from about 68 to about 38 trailing. That the drawdown is almost pure de rating of an unchanged franchise, rather than a response to falling earnings, is itself evidence the seller is repricing the multiple, not the business.

• The fifth force, owned honestly, a real miss. 5.6% organic against roughly 7.1% consensus, the first genuine disappointment in years. Part of the seller is rationally repricing the never misses premium. This is a fundamental repricing, not a mispricing, and the valuation section does not treat the entire fall as sentiment.

  
  

Inference: the marginal seller is still predominantly mechanical and sentiment driven, but not purely, and the sizing reflects that the fall is not one hundred percent noise.

SECTION FOUR, VALUATION, NOW THAT PRICE IS ADMITTED The current multiple. Roughly EUR 1,627 against roughly EUR 43 of 2025 earnings is about 38 times trailing; on reduced forward estimates, the low thirties. The business behind it: +9% constant currency revenue growth in 2025, a 41% recurring operating margin, roughly EUR 3.9bn adjusted free cash flow, roughly EUR 12.2bn net cash (tier one).

Reverse DCF, what each price assumes. (Illustrative; 8.5% discount rate, 2.5% terminal growth; all inputs disputable and stated for that purpose.) On FY2025 net profit of ~€4.5bn against EV of ~€159bn, the current price implies roughly 12% earnings compounding sustained for ten years (~14% if run on the €3.9bn reported FCF, which is currently depressed by the capacity build; ~10–12% at an 8.0% rate). For calibration, the €2,957 peak implied high-teens compounding. That is acceleration the model cannot deliver at a ~6–7% capacity cadence. And the reserve-tranche tail price of ~€1,165 implies only ~7%, below the group's demonstrated rate in almost every year of the modern record. The quantitative meaning of the de-rating: at 68x the price required acceleration; at 38x it requires persistence; at 27x it would require mere adequacy. The entry does not depend on multiple expansion, which is the spine of the case restated in DCF terms.

EPS bridge (analyst assumptions, pending full model). FY2026E EPS ~€44–45: revenue +7–8% cc, H1 margin dipping toward ~39.5–40% on under-absorption before recovering as workshops season; FY2027–30: revenue +8–9% (capacity ~6–7% + price/mix), margin normalising ~41%, EPS compounding ~9–10% to ~€65 by 2030.

The drawdown record, with trough multiples:

Episode	Peak to trough drawdown	Approx. trough trailing P/E
2001, dotcom	about 47%	about 24
2002	about 50%	about 19
2008, financial crisis, first leg	about 45%	about 23
2009, financial crisis, second leg	about 50%	about 24
November 2010	about 28%	about 34
2015 to 2016	about 22%	about 31
2018	about 27%	about 35
COVID, 2020	about 30%	about 35
2021 to 2022	about 43%	about 38
Current, 2025 to 2026	about 45%	about 38

The two regime framing, stated without the statistical overclaim. 

The record divides into a pre 2018 regime (troughs mid twenties to low thirties, centring about 27) and a post 2018 regime (troughs about 35 to 38, centring about 36), the re rating underpinned by margin rising from about 30% to 41%, fifteen further years of compounding proof, and, critically, a low rate environment. Three post 2018 bottoms (2018, 2020, 2021 to 2022) each found support at 35 to 38 and none revisited the old lows. This is a pattern and a plausibility, not a probability: three observations do not make a base rate. What the pattern does establish is the cost of the wrong benchmark. Anchoring on pre 2018 cheapness would have refused all three modern bottoms and forfeited the large runs that followed each. Demanding pre 2018 cheapness in a post 2018 world has been a systematically punished error.

The live threat to the regime floor.  One pillar of the post 2018 regime, low rates, has reversed. The ECB has flagged a possible further hike, US inflation is at multi year highs, high growth multiples are compressing, and sell side targets have been cut across the board (EUR 2,000 at Jefferies, EUR 1,700 at Barclays). None of the three modern bottoms formed against a tightening backdrop; this one would. Separately, Kepler Cheuvreux projects roughly 100 basis points of H1 margin contraction from fixed cost underabsorption as the capacity build runs ahead of decelerating revenue, so the earnings denominator itself is softer than in any of the three prior episodes. Both facts raise the probability of the lower tail, a re rating toward the pre 2018 trough of about 27, implying a price near EUR 1,165, roughly 29% below current, relative to a naive read of the three prior bottoms.

Why the entry does not depend on winning the regime argument.  This is the point that makes the spine hold. The recovery does not require the multiple to expand, or even to be defended at 38. If the moat holds and earnings compound at high single digits, the price recovers on earnings growth alone at an unchanged multiple, and recovers far faster if the multiple reverts toward the modern range. The regime question therefore governs the pace and the shape of the return, not whether there is one. The one scenario that breaks the recovery is not a lower multiple, it is the moat failing, because only then do the earnings stop compounding. This is why the lower tail is sized as a reserve conditional on the moat still passing, and why a fall through the pre 2018 trough is read as a possible moat signal rather than a simple discount.

Why deployment still follows, the asymmetry of errors.  Since the regime question cannot be resolved in advance, every bear case at every prior bottom also sounded structural at the time, the decision rests not on predicting the regime but on comparing the two ways of being wrong. Error one, buy and the regime breaks: the position marks down roughly 29% to the pre 2018 trough on a franchise still compounding earnings, with pre committed exits capping the loss if the moat itself breaks, a bounded and recoverable error. Error two, abstain and the moat holds: the recovery that has followed every prior verified moat drawdown is missed entirely, historically an unbounded and unrecoverable error of omission. The expected cost of error two dominates the expected cost of error one across any reasonable weighting, and that asymmetry, not a claimed base rate, is what justifies deploying. The live rate and margin threats do not change whether to deploy; they set how much is committed now and how much is reserved for the tail.

Scenarios (5-year, to mid-2031; dividends ~1.0–1.3% incl. specials; exit multiples on trailing EPS).

Scenario	Prob.	Mechanism	2030E EPS	Exit P/E	Price	IRR
Bull: multiple reverts to top of sustainable modern range	20%	Regime holds + China cohort returns	~€68	~47x	~€3,200	~+15%
Base: regime floor holds, earnings carry the return	50%	Moderate branch confirmed	~€65	~40x	~€2,600	~+11%
Tail: regime breaks, moat intact	20%	Rate-driven re-rating to pre-2018 band	~€60	~27x	~€1,620	~+1% (dead money; interim mark -29%)
Thesis break: moat fails	10%	Triggers exit tranche 1	—	—	—	realized ~-30% one-off, capped by triggers
Probability-weighted						~+8–9%

Three readings matter. First, the base case pays ~11% for the persistence of a business whose persistence is the best-evidenced fact in the file. Second, the tail is dead money, not impairment: a still-compounding 41%-margin net-cash franchise at 27x is a bad outcome measured in opportunity cost, not capital loss; this is the quantified, defensible form of the asymmetry-of-errors argument. Third, the weighted ~8–9% is modest against the hurdle precisely because the tail probabilities are set punitively; the trigger framework exists to truncate the break branch and the reserve tranche exists to convert the tail from pure cost into a better entry, both improve realized EV above the naive table.

Valuation verdict.

Against the regime that has governed since 2018, roughly 38 times trailing is at the modern floor; against the risk that the rate cycle breaks that regime, it is a floor under live test. The quality benchmarks are intact (41% margin today, ROIC above the 20% floor, net cash, elite conversion), so there is no fundamental erosion justifying a discount to the modern regime, though there is a macro force that could impose one anyway. The honest reading: attractive, with a fatter lower tail than a naive drawdown read would assign, which is a sizing instruction, not a rejection.

SECTION FIVE, THE PLAN, TWO TRANCHES

The plan is a framework fixed in the calm of the analysis, not a live order. It rests on the spine: the moat is intact, so the entry follows from the dislocation, and the durability of the moat, the future clause, is treated as a monitored variable with pre committed triggers. Deployment is split into two tranches, and the 29 July print governs derisking the first, not releasing the second.

The two tranches

• Tranche one, the majority, now. Justified directly by the spine: the moat is intact on the Q1 data, earnings are compounding at +9% core leather, and the price sits at the post 2018 regime floor during the largest drawdown since the dotcom crash. The dislocation is the opportunity and it is open only while the mispricing is live; waiting for confirmation waits for the discount to close. Roughly two thirds of the intended position is deployed here.

• Tranche two, the reserve, for the pre 2018 tail. Roughly one third is reserved for the single lower probability scenario that would offer a materially better entry: a re rating toward the pre 2018 trough of about 27 times, a price near EUR 1,165, roughly 29% below current and roughly 60% below the 2025 peak. This tranche is deployed at that level only if the moat retest still passes there. A fall through the pre 2018 trough would more plausibly signal the moat breaking than a simple de rating, so this tranche is conditional on fresh verification, never mechanical on price. It is the smaller share precisely because it is the lower probability branch.

There is no third tranche gated on a good print. Gating deployment on a confirming 29 July reading would mean buying back the discount after the market has closed it, which is self defeating for a dislocation trade. The print instead governs whether tranche one is kept, trimmed or exited.

The 29 July checkpoint, mechanical, not interpretive Interpretive language is where discipline dies in the heat of a red print, so the triggers are fixed now, in advance. They govern the deployed tranche one; where two rows conflict, the more defensive action governs.

29 July H1 reading	Pre committed action on the deployed tranche
Asia ex Japan at or above +3% constant currency, and core leather at or above +7% constant currency	Moderate branch confirmed. Hold the deployed tranche in full. Thesis on track.
Asia ex Japan between 0% and +3% constant currency, tourism and geopolitical attribution	Hold the deployed tranche. No trimming. Continue monitoring toward the Q3 print.
Asia ex Japan below 0% constant currency, attribution still tourism and geopolitical	Trim the deployed tranche by half. Pivot to active monitoring for the severe branch.
Asia ex Japan below 0% constant currency and management or channel evidence frames it as demand, or core leather below +6% constant currency	Severe branch. Thesis break. Exit the deployed tranche in full, regardless of price.
H1 recurring operating margin below 39%, more than 200 basis points under FY2025	Trim signal independent of the China reading. Below 38%, trim the deployed tranche by half.
Average Birkin and Kelly resale premium prints below 1.25 times retail on the next two quarterly readings	Pre impairment signal. Freeze the reserve tranche pending the decomposition below. Below 1.2 times sustained, Layer 1 thesis break applies.

The checkpoint reads three variables, China momentum, the H1 margin and the resale premium trend, not one, and the resale decomposition task from Section two is due before the print so that a soft premium reading can be classified as supply driven or demand driven on the day rather than debated afterwards. If 29 July disappoints on the severe branch, the response is to derisk: trim or exit tranche one per the table, and pivot, because at that point the market may be repricing the moat rather than the sentiment, and the spine’s one breaking condition, the moat failing, would be in play.

Sizing and portfolio context This is a full conviction candidate within the Layer 1 single name cap on the active sleeve, and the cap is what makes the asymmetry safe to act on. At the cap, a worst case realised loss on the fully deployed position, thesis break confirmed and exit executed through the stops, costs the portfolio a bounded and pre accepted amount that does not impair the ability to run the strategy. The staging bounds it further: only tranche one is exposed to the 29 July print, and tranche two cannot deploy without fresh moat verification. No error available in this plan is fatal at the portfolio level, and that is the licence for everything above it.

Exit, defined in advance

• Valuation normalisation: trim or exit as the trailing multiple re rates toward the upper end of the modern range. Note this target is deliberately set below the roughly 68 times bubble peak this drawdown began from, which is not a level to underwrite a return to; the mid forties to lower fifties is the top of the range the multiple has held outside spikes (year end 2023 about 49, 2024 about 54). On an intact franchise, reversion to that band is what the trade exists to capture, and it sits on top of the earnings compounding that carries the recovery even without it.

• Thesis break, overriding price: exit if any Layer 1 invalidation condition confirms during the hold, core leather below the band sustained, the resale premium below 1.2 times sustained or the decomposition attributing the compression predominantly to demand, discipline abandoned, or the China read moving structurally to the severe branch per the trigger table. A confirmed thesis break overrides the valuation target, because it means the earnings compounding on which the whole recovery depends has stopped.

ASSESSMENT SUMMARY Trigger: roughly 45% drawdown from the February 2025 high, through the Layer 1 threshold, the multiple compressed from about 68 times trailing at the peak (a bubble level matching 2021) to roughly 38 times now, a near halving that, with earnings roughly flat across the window, is almost entirely de rating rather than a response to falling earnings.

• Moat verdict: intact, five conditions clean and one amber. Core leather +9% constant currency, production discipline committed to 2030, governance unchanged, no near term migration signal but multi year indicators worsened at the margin, and the apex resale premium amber on a barbell, the blended auction premium at about 1.4 times with common formats near 1.0 times and scarce formats still rich, part of the compression sourced to the house's own supply expansion, decomposition due before 29 July.

• Nature of the decline: predominantly cyclical and exogenous, currency, a Middle East shock, sector de rating, China proxy selling and an extreme multiple unwinding, plus one owned fundamental component, a real Q1 miss that cracked the invincibility premium.

• The recovery mechanism: the moat holds, so earnings compound, so the price recovers even at an unchanged multiple and powerfully if the multiple reverts. The only condition that breaks this is the moat failing, which is why moat durability, not the multiple, is what the plan monitors.

• Valuation: at the post 2018 regime floor, with that floor under live test from a turning rate cycle and projected margin compression that none of the three prior modern bottoms faced. Attractive, with a fatter lower tail than a naive drawdown read would assign.

• The engine of the decision is the asymmetry of errors, not a base rate: buying wrong costs a bounded roughly 29% mark down on a compounding franchise with exits underneath; abstaining wrong repeats the unbounded omission that refusing 2018, 2020 and 2022 would have been.

• Plan, two tranches: roughly two thirds now at the regime floor, nothing gating this tranche; roughly one third reserved for the pre 2018 tail at about 27 times, deployed there only on fresh moat verification. The 29 July print is a derisk checkpoint on the deployed tranche, governed by mechanical triggers; a severe branch print trims or exits it and pivots. Exit on normalisation toward the mid forties to lower fifties (the top of the sustainable modern range, not the roughly 68 times bubble peak) or on any confirmed thesis break. All of it inside the Layer 1 cap, under which no available error is fatal at the portfolio level.

Layer 1 anticipated this scenario: a great franchise sold hard, mostly for reasons unrelated to its moat, while the core engine kept running. The evidence substantially confirms it, though not perfectly, and the imperfections, an amber resale gauge, a partly real miss, and a rate cycle testing the valuation floor, are carried in the sizing rather than argued away. The case does not need the market to be irrational or a secret to be known. It needs the moat to hold, and it monitors exactly that. The price is never the reason to buy; the intact moat, and the earnings compounding it protects, is. The checkpoints govern whether the position is kept and completed, not whether it is started.

A note on what these documents are and are not. The research published on this site is written for the author's own investment process and published in that form. Each document reflects the analysis, assumptions and judgment of the author at the date of writing and nothing more. Nothing on this site constitutes investment advice, a recommendation tailored to any reader, or an offer or solicitation to buy or sell any security. Valuation figures, scenarios and price levels are illustrative analyst assumptions unless explicitly sourced to company reports or other primary data. Investing involves risk, including the possible loss of capital, and past performance is no guarantee of future results. Any reader considering an investment should do their own work and consult a qualified financial adviser who knows their situation. The author may hold, or may come to hold, positions in the securities discussed.